TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B OF A CHILD AFFECTED WITH DRUG-RESISTANT VISCERAL LEISHMANIASIS

被引：13
|
作者：
GIACCHINO, R
GIAMBARTOLOMEI, G
TASSO, L
TIMITILLI, A
CASTAGNOLA, E
BRISIGOTTI, M
MICALIZZI, C
机构：
[1] G GASLINI CHILDRENS HOSP,DEPT PATHOL,GENOA,ITALY
[2] G GASLINI CHILDRENS HOSP,DEPT HAEMATOL,GENOA,ITALY
来源：
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 1993年 / 87卷 / 03期
关键词：
D O I：
10.1016/0035-9203(93)90141-C
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [41] Single-dose liposomal amphotericin B for visceral leishmaniasis
    Kshirsagar, Nilima A.
    LANCET GLOBAL HEALTH, 2014, 2 (04): : E203 - E203
  • [42] Amphotericin B: A drug of choice for Visceral Leishmaniasis
    Kumari, Shobha
    Kumar, Vikash
    Tiwari, Ritesh Kumar
    Ravidas, Vidyanand
    Pandey, Krishna
    Kumar, Ashish
    ACTA TROPICA, 2022, 235
  • [43] VISCERAL LEISHMANIASIS UNRESPONSIVE TO CONVENTIONAL THERAPIES - VALUE OF AMPHOTERICIN-B
    BERNARD, E
    QUARANTA, JF
    DURANT, J
    LEFICHOUX, Y
    DELLAMONICA, P
    PATHOLOGIE BIOLOGIE, 1993, 41 (8BIS): : 817 - 819
  • [44] EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT AND SECONDARY PROPHYLAXIS OF VISCERAL LEISHMANIASIS IN HIV-INFECTED PATIENTS - REPORT OF 2 CASES
    DUPLA, ML
    AGUADO, AG
    URIOL, PL
    GARCIA, VP
    ORTEGA, EV
    MARTINEZ, PM
    GARCIAPUIG, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (04) : 657 - 659
  • [45] Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
    Morizot, Gloria
    Jouffroy, Romain
    Faye, Albert
    Chabert, Paul
    Belhouari, Katia
    Calin, Ruxandra
    Charlier, Caroline
    Miailhes, Patrick
    Siriez, Jean-Yves
    Mouri, Oussama
    Yera, Helene
    Gilquin, Jacques
    Tubiana, Roland
    Lanternier, Fanny
    Mamzer, Marie-France
    Legendre, Christophe
    Peyramond, Dominique
    Caumes, Eric
    Lortholary, Olivier
    Buffet, Pierre
    PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (01):
  • [46] TREATMENT OF DEEP MYCOSES WITH LIPOSOMAL AMPHOTERICIN-B
    BERENGUER, J
    MUNOZ, P
    PARRAS, F
    FERNANDEZBACA, V
    HERNANDEZSAMPELAYO, T
    BOUZA, E
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (06) : 504 - 507
  • [47] Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient
    Alsina-Gibert, Merce
    Lopez-Lerma, Ingrid
    Martinez-Chamorro, Esteban
    Herrero-Mateu, Carme
    ARCHIVES OF DERMATOLOGY, 2006, 142 (06) : 787 - 789
  • [48] US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis - Editorial response
    Berman, JD
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (01) : 49 - 51
  • [49] Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
    Machado, Paulo R. L.
    Rosa, Maria Elisa A.
    Guimaraes, Luis H.
    Prates, Fernanda V. O.
    Queiroz, Adriano
    Schriefer, Albert
    Carvalho, Edgar M.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) : 945 - 949
  • [50] Visceral leishmaniasis in renal transplant recipients: Successful treatment with liposomal amphotericin B (AmBisome)
    Boletis, JN
    Pefanis, A
    Stathakis, C
    Helioti, H
    Kostakis, A
    Giamarellou, H
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) : 1308 - 1309
12345